ACTRN12610000114044已完成1 期
Oral N-acetylcysteine in the Treatment of Raynaud's Phenomenon Secondary to Systemic Sclerosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Foundation for the support for research in the state of Sao Paulo0 个研究点目标入组 40 人开始时间: 2010年2月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Raynaud phenomenon secondary to systemic sclerosis with pain
排除标准
- •smokers and diabetes
研究者
相似试验
已完成
2 期
Acetylcysteine Augmentation in Treatment of Refractory Obsessive-Compulsive DisorderObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT201103243930N4Vice chancellor for research, Shiraz University of Medical Sciences40
尚未招募
不适用
Efficacy of the oral use of the drug N-acetylcysteine in the treatment of facial melasma in womeMelasmaRBR-73zrnjhFaculdade de Medicina de Botucatu (FMB - Unesp)
尚未招募
3 期
Acetyl Cysteine in the management of Zinc Phosphide PoisoningCTRI/2024/03/064278J.L.N Medical College and Hospital
招募中
2 期
Oral N-acetylcysteine (NAC) effectiveness in cystic fibrosis (CF)IRCT20090808002306N7Esfahan University of Medical Sciences45
招募中
2 期
Evauating the effects of oral N-acetylcysteinas in comparing with pregabalin for pain managementinpatients with painful diabetic neuropathy.IRCT20180814040795N1Hamedan University of Medical Sciences140